TEAM:NASDAQAtlassian Corporation Analysis

Atlassian posted a **32% revenue surge** in Q3, driven by cloud expansion and AI‑enhanced product launches, lifting the forward earnings estimate to $6.21 per share while trailing EPS remains negative. The stock trades at $89.01, well below the DCF‑derived fair value of $201, implying roughly a **60% upside** and positioning the shares as **undervalued** relative to intrinsic expectations. Technicals are mixed: the 20‑day SMA sits above the price, the 200‑day SMA remains far higher, RSI is at 58 indicating neutral momentum, and the MACD histogram is negative, suggesting short‑term bearish pressure amid decreasing volume. Despite a **high 30‑day volatility of over 100%** and a historic max drawdown of 74%, the beta of 0.77 points to lower systematic risk compared with the broader market. Recent news amplified sentiment – an 8.1% price jump followed a high‑profile political visit, and prominent investors such as Steve Cohen highlighted the stock’s upside potential. Overall, the combination of robust top‑line growth, a substantial valuation gap, and improving cash flow supports a **buy** thesis, though execution risk and current profitability challenges temper optimism.